Additional buy…
$ARS Pharmaceuticals (SPRY.US)$ AQST-Reiterates expected timing for filing of New Drug Application (NDA) for Anaphylm™ (epinephrine) Sublingual Film to the FDA in the first quarter of 2025… this is a perfect companion stock to add for food allergies treatment, IMHO
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
